{
    "clinical_study": {
        "@rank": "70779", 
        "arm_group": [
            {
                "arm_group_label": "Arm I", 
                "arm_group_type": "Placebo Comparator", 
                "description": "Patients receive oral placebo twice daily on days -3 to 3 of chemotherapy courses 2 and 3."
            }, 
            {
                "arm_group_label": "Arm II", 
                "arm_group_type": "Experimental", 
                "description": "Patients receive oral low-dose ginger and oral placebo twice daily on days -3 to 3 of chemotherapy courses 2 and 3."
            }, 
            {
                "arm_group_label": "Arm III", 
                "arm_group_type": "Experimental", 
                "description": "Patients receive oral intermediate-dose ginger and oral placebo twice daily on days -3 to 3 of chemotherapy courses 2 and 3."
            }, 
            {
                "arm_group_label": "Arm IV", 
                "arm_group_type": "Experimental", 
                "description": "Patients receive oral high-dose ginger twice daily on days -3 to 3 of chemotherapy courses 2 and 3."
            }
        ], 
        "brief_summary": {
            "textblock": "RATIONALE: Ginger may help reduce or prevent nausea. It is not yet known if antiemetic drugs\n      are more effective with or without ginger in treating nausea caused by chemotherapy.\n\n      PURPOSE: This randomized phase II/III trial is studying giving antiemetic drugs together\n      with ginger to see how well they work compared to antiemetic drugs alone in treating nausea\n      in patients who are receiving chemotherapy for cancer."
        }, 
        "brief_title": "Ginger in Treating Nausea in Patients Receiving Chemotherapy for Cancer", 
        "completion_date": {
            "#text": "April 2010", 
            "@type": "Actual"
        }, 
        "condition": [
            "Nausea and Vomiting", 
            "Unspecified Adult Solid Tumor, Protocol Specific"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Nausea", 
                "Vomiting"
            ]
        }, 
        "detailed_description": {
            "textblock": "OBJECTIVES:\n\n        -  Compare the efficacy of 1 course of ginger vs placebo when administered in regimens\n           containing a 5-hydroxytryptamine type 3 (5-HT3) receptor antagonist antiemetic and\n           dexamethasone (or the equivalent dose of IV methylprednisolone) in controlling\n           chemotherapy-related nausea at course 2 of chemotherapy in patients with cancer.\n\n        -  Compare the efficacy of 3 different doses of ginger in controlling chemotherapy-related\n           nausea in these patients.\n\n        -  Determine the adverse effects of ginger when given 3 days before chemotherapy\n           administration in these patients.\n\n        -  Determine the adverse effects of these antiemetic regimens during the 4 days after\n           chemotherapy.\n\n        -  Compare the chemotherapy-related anticipatory nausea in patients treated with these\n           antiemetic regimens.\n\n        -  Compare the quality of life during the 4 days after chemotherapy in patients treated\n           with these antiemetic regimens.\n\n        -  Compare the chemotherapy-related nausea at course 3 of chemotherapy in these patients\n           after 2 courses of ginger vs placebo.\n\n      OUTLINE: This is a randomized, double-blind, placebo-controlled, multicenter study. Patients\n      are stratified according to participating center. Patients are randomized to 1 of 4\n      treatment arms. Day 1 of each course is defined as the day of chemotherapy administration.\n\n        -  Arm I: Patients receive oral placebo twice daily on days -3 to 3 of chemotherapy\n           courses 2 and 3.\n\n        -  Arm II: Patients receive oral low-dose ginger and oral placebo twice daily on days -3\n           to 3 of chemotherapy courses 2 and 3.\n\n        -  Arm III: Patients receive oral intermediate-dose ginger and oral placebo twice daily on\n           days -3 to 3 of chemotherapy courses 2 and 3.\n\n        -  Arm IV: Patients receive oral high-dose ginger twice daily on days -3 to 3 of\n           chemotherapy courses 2 and 3.\n\n      Patients in each arm also continue receiving their scheduled antiemetic regimen comprising a\n      5-hydroxytryptamine type-3 (5-HT3) receptor antagonist (ondansetron, granisetron,\n      tropisetron, and dolasetron mesylate) and dexamethasone (DM) (or the equivalent dose of IV\n      methylprednisolone (MePRDL)) on day 1 of courses 2 and 3.\n\n      Symptoms are assessed on day -3 to day 1 of courses 2 and 3 and on days 1-4 of courses 1-3.\n\n      Quality of life is assessed on day 4 of courses 1-3.\n\n      Nausea and vomiting are assessed 4 times daily on days 1-4 of courses 1-3.\n\n      PROJECTED ACCRUAL: A total of 706 patients will be accrued for this study within 3 years."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "DISEASE CHARACTERISTICS:\n\n          -  Diagnosis of cancer and be scheduled to receive at least 3 courses of chemotherapy\n\n               -  Scheduled to receive chemotherapy with no planned interruption by radiotherapy\n                  or surgery\n\n               -  Chemotherapy courses must be separated by at least 2 weeks from day 1 to day 1\n                  of next course\n\n          -  Must have experienced nausea of any degree of severity after completion of the first\n             study-related course of chemotherapy\n\n          -  Received a prior 5-hydroxytryptamine type 3 (5-HT3) receptor antagonist antiemetic\n             (ondansetron, granisetron, tropisetron, or dolasetron mesylate) with dexamethasone\n             (DM) given at any dose and by any route (or equivalent dose of IV methylprednisolone\n             (MePRDL)) on day 1 of course 1 of chemotherapy\n\n          -  Scheduled to receive a 5-HT3 receptor antagonist antiemetic with DM (or equivalent\n             dose of IV MePRDL) on day 1 of courses 2 and 3 of chemotherapy\n\n          -  No symptomatic brain metastases\n\n        PATIENT CHARACTERISTICS:\n\n        Age:\n\n          -  18 and over\n\n        Performance status:\n\n          -  Not specified\n\n        Life expectancy:\n\n          -  Not specified\n\n        Hematopoietic:\n\n          -  Platelet count greater than 100,000/mm^3 at second course of chemotherapy\n\n          -  No prior bleeding or blood coagulation disorder (e.g., thrombocytopenia or platelet\n             dysfunction)\n\n        Hepatic:\n\n          -  No prior coagulation factor deficiency\n\n        Renal:\n\n          -  Not specified\n\n        Cardiovascular:\n\n          -  No prior vascular defect\n\n        Other:\n\n          -  Able to understand English\n\n          -  No concurrent or impending bowel obstruction\n\n        PRIOR CONCURRENT THERAPY:\n\n        Biologic therapy:\n\n          -  No concurrent interferon therapy\n\n        Chemotherapy:\n\n          -  See Disease Characteristics\n\n          -  At least 6 months since other prior chemotherapy\n\n        Endocrine therapy:\n\n          -  Not specified\n\n        Radiotherapy:\n\n          -  See Disease Characteristics\n\n          -  No concurrent radiotherapy\n\n        Surgery:\n\n          -  See Disease Characteristics\n\n        Other:\n\n          -  No concurrent warfarin or heparin for therapeutic anticoagulation\n\n          -  Concurrent low-dose warfarin for maintenance of venous access allowed\n\n          -  Concurrent rescue medications for control of symptoms caused by the cancer or its\n             treatment allowed as clinically indicated"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "706", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "July 8, 2002", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT00040742", 
            "org_study_id": "CDR0000069401", 
            "secondary_id": [
                "U10CA037420", 
                "URCC-U1902", 
                "URCC-0114", 
                "NCI-5857", 
                "NCI-P02-0223"
            ]
        }, 
        "intervention": [
            {
                "arm_group_label": [
                    "Arm II", 
                    "Arm III", 
                    "Arm IV"
                ], 
                "description": "Given orally", 
                "intervention_name": "ginger extract", 
                "intervention_type": "Dietary Supplement"
            }, 
            {
                "arm_group_label": [
                    "Arm I", 
                    "Arm II", 
                    "Arm III"
                ], 
                "description": "Given orally", 
                "intervention_name": "placebo", 
                "intervention_type": "Other"
            }
        ], 
        "is_fda_regulated": "No", 
        "keyword": [
            "nausea and vomiting", 
            "unspecified adult solid tumor, protocol specific"
        ], 
        "lastchanged_date": "November 8, 2010", 
        "link": {
            "description": "Clinical trial summary from the National Cancer Institute's PDQ\u00ae database", 
            "url": "http://cancer.gov/clinicaltrials/URCC-U1902"
        }, 
        "location": [
            {
                "facility": {
                    "address": {
                        "city": "Mobile", 
                        "country": "United States", 
                        "state": "Alabama", 
                        "zip": "36606"
                    }, 
                    "name": "MBCCOP - Gulf Coast"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Honolulu", 
                        "country": "United States", 
                        "state": "Hawaii", 
                        "zip": "96813"
                    }, 
                    "name": "MBCCOP - Hawaii"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Chicago", 
                        "country": "United States", 
                        "state": "Illinois", 
                        "zip": "60612-7323"
                    }, 
                    "name": "MBCCOP - University of Illinois at Chicago"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Decatur", 
                        "country": "United States", 
                        "state": "Illinois", 
                        "zip": "62526"
                    }, 
                    "name": "CCOP - Central Illinois"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Wichita", 
                        "country": "United States", 
                        "state": "Kansas", 
                        "zip": "67214-3882"
                    }, 
                    "name": "CCOP - Wichita"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Grand Rapids", 
                        "country": "United States", 
                        "state": "Michigan", 
                        "zip": "49503"
                    }, 
                    "name": "CCOP - Grand Rapids"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Kalamazoo", 
                        "country": "United States", 
                        "state": "Michigan", 
                        "zip": "49007-3731"
                    }, 
                    "name": "CCOP - Kalamazoo"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "St. Louis Park", 
                        "country": "United States", 
                        "state": "Minnesota", 
                        "zip": "55416"
                    }, 
                    "name": "CCOP - Metro-Minnesota"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Kansas City", 
                        "country": "United States", 
                        "state": "Missouri", 
                        "zip": "64131"
                    }, 
                    "name": "CCOP - Kansas City"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Las Vegas", 
                        "country": "United States", 
                        "state": "Nevada", 
                        "zip": "89106"
                    }, 
                    "name": "CCOP - Nevada Cancer Research Foundation"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "East Syracuse", 
                        "country": "United States", 
                        "state": "New York", 
                        "zip": "13057"
                    }, 
                    "name": "CCOP - Hematology-Oncology Associates of Central New York"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Manhassett", 
                        "country": "United States", 
                        "state": "New York", 
                        "zip": "11030"
                    }, 
                    "name": "CCOP - North Shore University Hospital"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Goldsboro", 
                        "country": "United States", 
                        "state": "North Carolina", 
                        "zip": "27534-9479"
                    }, 
                    "name": "CCOP - Southeast Cancer Control Consortium"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Columbus", 
                        "country": "United States", 
                        "state": "Ohio", 
                        "zip": "43215"
                    }, 
                    "name": "CCOP - Columbus"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Portland", 
                        "country": "United States", 
                        "state": "Oregon", 
                        "zip": "97225"
                    }, 
                    "name": "CCOP - Columbia River Oncology Program"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Greenville", 
                        "country": "United States", 
                        "state": "South Carolina", 
                        "zip": "29615"
                    }, 
                    "name": "CCOP - Greenville"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Spartanburg", 
                        "country": "United States", 
                        "state": "South Carolina", 
                        "zip": "29303"
                    }, 
                    "name": "CCOP - Upstate Carolina"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Tacoma", 
                        "country": "United States", 
                        "state": "Washington", 
                        "zip": "98405-0986"
                    }, 
                    "name": "CCOP - Northwest"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Marshfield", 
                        "country": "United States", 
                        "state": "Wisconsin", 
                        "zip": "54449"
                    }, 
                    "name": "CCOP - Marshfield Clinic Research Foundation"
                }
            }
        ], 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_arms": "4", 
        "official_title": "A Phase II/III Randomized, Controlled Clinical Trial Of Ginger (Zingiber Officinale) For Nausea Caused By Chemotherapy For Cancer", 
        "overall_official": {
            "affiliation": "University of Rochester", 
            "last_name": "Julie L. Ryan, PhD, MPH", 
            "role": "Study Chair"
        }, 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "United States: Federal Government"
        }, 
        "phase": "Phase 2/Phase 3", 
        "primary_completion_date": {
            "#text": "December 2008", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "measure": "Efficacy of ginger on chemotherapy-related nausea as determined by Nausea and Vomiting Diary at course 2 (approximately 3-4 weeks on study drug)", 
            "safety_issue": "No"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT00040742"
        }, 
        "secondary_outcome": [
            {
                "measure": "Effective dose of ginger for chemotherapy-related nausea as determined by Nausea and Vomiting Diary and Symptom Inventory at course 2 (approximately 3-4 weeks on study drug)", 
                "safety_issue": "No"
            }, 
            {
                "measure": "Adverse effects of ginger as determined by Symptom Inventory, Platelet Count Form, and AE Report at course 3", 
                "safety_issue": "Yes"
            }, 
            {
                "measure": "Efficacy of ginger on chemotherapy-related anticipatory nausea as determined by Nausea and Vomiting Diary and Symptom Inventory at course 3 (approximately 6-8 weeks on study drug)", 
                "safety_issue": "No"
            }, 
            {
                "measure": "Quality of life by  Functional Assessment Cancer Therapy-General at course 3 (approximately 6-8 weeks on study drug)", 
                "safety_issue": "No"
            }, 
            {
                "measure": "Efficacy of ginger on chemotherapy-related nausea as determined by  Nausea and Vomiting Diary at course 3 (approximately 6-8 weeks on study drug)", 
                "safety_issue": "No"
            }
        ], 
        "source": "University of Rochester", 
        "sponsors": {
            "collaborator": {
                "agency": "National Cancer Institute (NCI)", 
                "agency_class": "NIH"
            }, 
            "lead_sponsor": {
                "agency": "University of Rochester", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "March 2003", 
        "study_design": "Allocation: Randomized, Masking: Double-Blind, Primary Purpose: Supportive Care", 
        "study_type": "Interventional", 
        "verification_date": "November 2010"
    }, 
    "geocoordinates": {
        "CCOP - Central Illinois": "39.84 -88.955", 
        "CCOP - Columbia River Oncology Program": "45.523 -122.676", 
        "CCOP - Columbus": "39.961 -82.999", 
        "CCOP - Grand Rapids": "42.963 -85.668", 
        "CCOP - Greenville": "34.853 -82.394", 
        "CCOP - Hematology-Oncology Associates of Central New York": "43.065 -76.079", 
        "CCOP - Kalamazoo": "42.292 -85.587", 
        "CCOP - Kansas City": "39.1 -94.579", 
        "CCOP - Marshfield Clinic Research Foundation": "44.669 -90.172", 
        "CCOP - Metro-Minnesota": "44.96 -93.37", 
        "CCOP - Nevada Cancer Research Foundation": "36.115 -115.173", 
        "CCOP - North Shore University Hospital": "40.798 -73.7", 
        "CCOP - Northwest": "47.253 -122.444", 
        "CCOP - Southeast Cancer Control Consortium": "35.385 -77.993", 
        "CCOP - Upstate Carolina": "34.95 -81.932", 
        "CCOP - Wichita": "37.692 -97.337", 
        "MBCCOP - Gulf Coast": "30.694 -88.043", 
        "MBCCOP - Hawaii": "21.307 -157.858", 
        "MBCCOP - University of Illinois at Chicago": "41.878 -87.63"
    }
}